Chemical Compound Review:
DOPEG 4-(1,2- dihydroxyethyl)benzene-1,2- diol
Synonyms:
SureCN141609, CHEBI:1387, AG-F-12743, ACMC-20mcm9, D9753_SIGMA, ...
- Measurement of norepinephrine and 3,4-dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma. Duncan, M.W., Compton, P., Lazarus, L., Smythe, G.A. N. Engl. J. Med. (1988)
- Dihydroxyphenylglycol in pheochromocytoma: its diagnostic use for norepinephrine dominant tumor. Nakada, T., Sasagawa, I., Kubota, Y., Suzuki, H., Ishigooka, M., Watanabe, M. J. Urol. (1996)
- Subacute toxicity of 1,1,1-trichloroethane, noise, and their combination in rats. Blohm, M., Braun, H., Kaschny, P., Schill, W., Jastorff, B., Diehl, H. Ecotoxicol. Environ. Saf. (1985)
- Effect of digitalis glycosides on norepinephrine release in the heart. Dual mechanism of action. Kranzhöfer, R., Haass, M., Kurz, T., Richardt, G., Schömig, A. Circ. Res. (1991)
- Monoamine oxidase A and B activities in heavy smokers. Berlin, I., Said, S., Spreux-Varoquaux, O., Olivares, R., Launay, J.M., Puech, A.J. Biol. Psychiatry (1995)
- Effluxes of 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylglycol, and norepinephrine from four blood vessels during basal conditions and during nerve stimulation. Tyce, G.M., Hunter, L.W., Ward, L.E., Rorie, D.K. J. Neurochem. (1995)
- The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. Breier, A., Buchanan, R.W., Waltrip, R.W., Listwak, S., Holmes, C., Goldstein, D.S. Neuropsychopharmacology (1994)
- Characterization of tritiated noradrenaline release from the rat preoptic area with microdialysis in vivo. Fernández-Galaz, C., Herbison, A.E., Dyer, R.G. J. Neurochem. (1993)
- Lack of circadian rhythm in plasma levels of 3,4-dihydroxyphenylethyleneglycol in healthy human subjects. Dennis, T., Benkelfat, C., Touitou, Y., Auzeby, A., Poirier, M.F., Scatton, B., Lôo, H. Psychopharmacology (Berl.) (1986)
- The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers. Penttilä, J., Syvälahti, E., Hinkka, S., Kuusela, T., Scheinin, H. Psychopharmacology (Berl.) (2001)
- Antenatal dexamethasone treatment decreases plasma catecholamine levels in preterm infants. Kallio, J., Karlsson, R., Toppari, J., Helminen, T., Scheinin, M., Kero, P. Pediatr. Res. (1998)
- Determination of 3,4-dihydroxyphenylethyleneglycol in urine by gas chromatography with a flame ionization detector: a new rapid method. Biondi, P.A., Fedele, G., Motta, A., Secchi, C. Clin. Chim. Acta (1979)
- Precursors and metabolites of norepinephrine in sympathetic ganglia of the dog. Kristensen, E.W., Chinnow, S.L., Montreuil, R.S., Tyce, G.M. J. Neurochem. (1990)
- Halothane decreases the release of neuropeptide Y and 3,4-dihydroxyphenylglycol from superfused segments of dog pulmonary artery. Rorie, D.K., Hunter, L.W., Lunn, J.J. Anesthesiology (1990)
- In vivo measurement of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: effects of various drugs affecting noradrenaline metabolism. Itoh, Y., Oishi, R., Nishibori, M., Saeki, K. J. Pharmacol. Exp. Ther. (1990)
- Altered release and metabolism of norepinephrine in superfused canine saphenous veins in the presence of halothane and hypoxia. Kamath, G.S., Rorie, D.K., Tyce, G.M. Anesthesiology (1993)
- Androgen induced norepinephrine release from postganglionic neurons mediates accessory sex organ smooth muscle proliferation. Kim, J., Cole, D., Johnson, A., Centenera, V., Schenkman, E., Durham, J., Azzaro, A., Mawhinney, M. J. Urol. (2002)
- Selective inhibition by hydrocortisone of 3H-normetanephrine formation during 3H-transmitter release elicited by nerve stimulation in the isolated nerve-muscle preparation of the cat nictitating membrane. Luchelli-Fortis, M.A., Langer, S.Z. Naunyn Schmiedebergs Arch. Pharmacol. (1975)
- Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine. Berlin, I., Chalon, S., Payan, C., Schöllnhammer, G., Cesselin, F., Varoquaux, O., Puech, A.J. British journal of clinical pharmacology. (1995)
- Determination of 3,4-dihydroxyphenylglycol (DHPG) by HPLC with coulometric detection, and correlation with 3-methoxy-4-hydroxyphenylglycol (MHPG) in human plasma. Karege, F., Gaillard, J.M., Tissot, R., Azorin, J.M., Valli, M. Biomed. Chromatogr. (1987)
- CR 2249: a new putative memory enhancer. Behavioural studies on learning and memory in rats and mice. Garofalo, P., Colombo, S., Lanza, M., Revel, L., Makovec, F. J. Pharm. Pharmacol. (1996)
- The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers. Van Haarst, A.D., Van Gerven, J.M., Cohen, A.F., De Smet, M., Sterrett, A., Birk, K.L., Fisher, A.L., De Puy, M.E., Goldberg, M.R., Musson, D.G. British journal of clinical pharmacology. (1999)
- The measurement of central noradrenergic activity in spontaneously hypertensive rats: a comparison of free 3,4-dihydroxyphenylethyleneglycol levels with FLA-63 induced noradrenaline depletion. Howes, L.G., Summers, R.J., Rowe, P.R., Louis, W.J. J. Hypertens. (1985)
- Determinants of short-term variation in arterial flow-mediated dilatation in healthy young men. Järvisalo, M.J., Jartti, L., Marniemi, J., Rönnemaa, T., Viikari, J.S., Lehtimäki, T., Raitakari, O.T. Clin. Sci. (2006)
- Lack of adverse interactions between concomitantly administered selegiline and citalopram. Laine, K., Anttila, M., Heinonen, E., Helminen, A., Huupponen, R., Mäki-Ikola, O., Reinikainen, K., Scheinin, M. Clinical neuropharmacology. (1997)
- Reflex sympathetic dystrophy: the significance of differing plasma catecholamine concentrations in affected and unaffected limbs. Drummond, P.D., Finch, P.M., Smythe, G.A. Brain (1991)